BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32721459)

  • 1. Nuclear imaging approaches facilitating nanomedicine translation.
    Pérez-Medina C; Teunissen AJP; Kluza E; Mulder WJM; van der Meel R
    Adv Drug Deliv Rev; 2020; 154-155():123-141. PubMed ID: 32721459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabelling of nanomaterials for medical imaging and therapy.
    Pellico J; Gawne PJ; T M de Rosales R
    Chem Soc Rev; 2021 Mar; 50(5):3355-3423. PubMed ID: 33491714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging-guided nanomedicine development.
    Bernal A; Calcagno C; Mulder WJM; Pérez-Medina C
    Curr Opin Chem Biol; 2021 Aug; 63():78-85. PubMed ID: 33735814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAMAM Dendrimer-Based Nanodevices for Nuclear Medicine Applications.
    Xiao T; Li D; Shi X; Shen M
    Macromol Biosci; 2020 Feb; 20(2):e1900282. PubMed ID: 31829523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabeling nanomaterials for multimodality imaging: New insights into nuclear medicine and cancer diagnosis.
    Ge J; Zhang Q; Zeng J; Gu Z; Gao M
    Biomaterials; 2020 Jan; 228():119553. PubMed ID: 31689672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced Methods for Radiolabeling Multimodality Nanomedicines for SPECT/MRI and PET/MRI.
    Lamb J; Holland JP
    J Nucl Med; 2018 Mar; 59(3):382-389. PubMed ID: 29025988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines.
    Edmonds S; Volpe A; Shmeeda H; Parente-Pereira AC; Radia R; Baguña-Torres J; Szanda I; Severin GW; Livieratos L; Blower PJ; Maher J; Fruhwirth GO; Gabizon A; T M de Rosales R
    ACS Nano; 2016 Nov; 10(11):10294-10307. PubMed ID: 27781436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting phosphatidylserine for radionuclide-based molecular imaging of apoptosis.
    Wuest M; Perreault A; Richter S; Knight JC; Wuest F
    Apoptosis; 2019 Apr; 24(3-4):221-244. PubMed ID: 30684144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical imaging: an essential ally in modern biosciences.
    Cunha L; Horvath I; Ferreira S; Lemos J; Costa P; Vieira D; Veres DS; Szigeti K; Summavielle T; Máthé D; Metello LF
    Mol Diagn Ther; 2014 Apr; 18(2):153-73. PubMed ID: 24146172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality imaging of nanoparticle-based vaccines: Shedding light on immunology.
    Younis MH; Tang Z; Cai W
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1807. PubMed ID: 35501142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis?
    Pant K; Sedláček O; Nadar RA; Hrubý M; Stephan H
    Adv Healthc Mater; 2017 Mar; 6(6):. PubMed ID: 28218487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions.
    Farzin L; Sheibani S; Moassesi ME; Shamsipur M
    J Biomed Mater Res A; 2019 Jan; 107(1):251-285. PubMed ID: 30358098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in Randomized Clinical Trials: Positron Emission Tomography and Nuclear Medicine Techniques.
    Singhal T; Stern E
    Front Neurol Neurosci; 2016; 39():109-16. PubMed ID: 27463807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Cell Radiolabeling for
    Gawne PJ; Man F; Blower PJ; T M de Rosales R
    Chem Rev; 2022 Jun; 122(11):10266-10318. PubMed ID: 35549242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Targeting Nuclear Molecular Imaging Driven by Tetrazine Bioorthogonal Chemistry.
    Dong P; Wang X; Zheng J; Zhang X; Li Y; Wu H; Li L
    Curr Med Chem; 2020; 27(23):3924-3943. PubMed ID: 31267851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nuclear medicine imaging: new radiotracers and future techniques].
    Semah F
    Neurochirurgie; 2008 May; 54(3):231-5. PubMed ID: 18440564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benchtop systems for in vivo molecular screening of labeled compounds, as a tool to speed up drug research.
    Loudos G; Georgiou M; Rouchota M; Papadimitroulas P; Fysikopoulos E
    Hell J Nucl Med; 2019; 22 Suppl 2():183. PubMed ID: 31802061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities.
    Agrahari V; Agrahari V
    Drug Discov Today; 2018 May; 23(5):974-991. PubMed ID: 29406263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor Occupancy Imaging Studies in Oncology Drug Development.
    Burvenich IJG; Parakh S; Parslow AC; Lee ST; Gan HK; Scott AM
    AAPS J; 2018 Mar; 20(2):43. PubMed ID: 29520671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of in vivo imaging in the evaluation of the pathophysiology of viral and bacterial infections and in development of countermeasures to BSL3/4 pathogens.
    Bocan TM; Panchal RG; Bavari S
    Mol Imaging Biol; 2015 Feb; 17(1):4-17. PubMed ID: 25008802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.